Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998
Regress of HIV Enceph & Basal Ganglia Signal Intensity Abnor MRI in AIDS after Protease Inhibitor
Neuroradiology 206:491-498, Filippi,C.G.,et al, 1998
Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Arch Int Med 158:1641-1647, Chiquette,E.,et al, 1998
Current Immunotherapy in Multiple Sclerosis
Immunology and Cell Biology 76:55-64, Bashir,K.&Whitaker,J.N., 1998
Intracranial Aneurysms
NEJM 336:28-40, Schievink,W.I., 1997
Lifestyle-Associated Risk Factors for Acute Brain Infarction Among Persons of Working Age
Stroke 28:26-30, Haapaniemi,H.,et al, 1997
HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
Long-Term Follow-up of Pts with SSPE Treated with Intraventricular alpha-Interferon
Neurol 48:526-528, Anlar,B.,et al, 1997
Remission of PML Following Splenectomy & Antiretroviral Therapy in a Pt with HIV Infection
NEJM 336:661-662, Power,C.,et al, 1997
Treatment of Ramsay Hunt Syndrome with Acyclovir-Prednisone:Sign of Early Dx & Trtm
Ann Neurol 41:353-357, Murakami,S.,et al, 1997
HIV Infection-1
BMJ 314:487-491, 579-5831997., Cohn,J.A., 1997
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Low-Velocity Graded Treadmill Stress Testing in Hemiparetic Stroke Patients
Stroke 28:988-992, Macko,R.F.,et al, 1997
A Prediction Model for Functional Recovery in Stroke
Stroke 28:550-556, Stineman,M.G.,et al, 1997
The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997
Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997
2-5 Yr Remission of AIDS-Assoc Progressive Multifocal Leukoencephalopathy with Combined Antiretroviral Therapy
Lancet 349:850, Elliot,B.,et al, 1997
Managing Chronic Fatigue Syndrome in Children
BMJ 314:1635-1636, 16471997., Marcovitch,H., 1997
Cardiac Cephalgia:A Treatable Form of Exertional Headache
Neurol 49:813-816, Lipton,R.B.,et al, 1997
Peripheral Neuropathy in HIV Infected Patients with the Diffuse Infiltrative Lymphocytosis Syndrome
Ann Neurol 41:438-445, Moulignier,A.,et al, 1997
Hearing Loss and Antiretroviral Therapy in Patients Infected with HIV-1
Arch Neurol 54:407-410, Marra,C.M.,et al, 1997
The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Randomised Controlled Trial to Evaluate Early Discharge Scheme for Patients with Stroke
BMJ 315:1039-1044, Rudd,A.G.,et al, 1997
Acute Stroke:Prognosis & Prediction of Effect of Med Treat Outcome & Health Care Util, Copenhagen Study
Neurol 49:1335-1342, Jorgensen,H.S.,et al, 1997
A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997
Warfarin Use Among Patients with Atrial Fibrillation
Stroke 28:2382-2389, Brass,L.M.,et al, 1997
Acute Low Back Pain:A New Paradigm for Management
BMJ 313:1343-1344, Deyo,R.A., 1996
Treatment of Rasmussen's Syndrome with Ganciclovir
Neurol 47:925-928, McLachlan,R.S.,et al, 1996
Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
Zoster Myelitis:Improvement with Antiviral Therapy in Two Cases
Neurol 47:929-931, deSilva,S.M.,et al, 1996
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
The Role of Lab Investig in the Dx & Management of Pts with Suspected Herpes Simplex Encephalitis:A Consensus Rpt
JNNP 61:339-345, Clinque,P.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Nonsystemic Vasculitic Mononeuropathy Multiplex, Cryoglobulinemia, and Hepatitis C
Muscle & Nerve 19:1596-1602996., David,W.S.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Transient Ara-C Leukoencephalopathy:MR Findings
J Comput Assist Tomogr 20:161-169, Patel,A.G.&Rao,R., 1996
Risk of Stroke During Long-Term Anticoagulant Therapy in Patients After Myocardial Infarction
Ann Neurol 39:301-307, 2811996., Azar,A.J.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996